Pharmacy

Your Article Summary

See Latest Articles

New investigational combination telmisartan and amlodipine shows effective and well-tolerated 24-hour blood pressure control in hypertensive patients at risk of cardiovascular events
Boehringer Ingelheim, 06/15/09

Data presented at the 19th Scientific Meeting of the European Society of Hypertension, Milan, Italy has demonstrated that treatment with an investigational combination of telmisartan and amlodipine shows substantial and sustained 24-hour blood pressure lowering and is well-tolerated in a range of patients with hypertension at risk of cardiovascular events. This includes patients with Type 2 diabetes, obese patients, the elderly, black patients and those not controlled by amlodipine alone

Today in Cardiac/Hypertension...keeping you current

Receive free subspecialty "5-minute updates" via email

Cost-effectiveness analysis of the use of a high-intensity statin compared to a low-intensity statin in the management of patients with familial hypercholesterolaemia
Current Medical Research and Opinion, 12/18/09

Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study
Age and Aging, 12/18/09

Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia
Lipids in Health and Disease, 12/18/09

 See all of Cardiac/Hypertension

Today in Drug Interactions...keeping you current

Receive free subspecialty "5-minute updates" via email

Semi-Mechanistic Population Pharmacokinetic Drug-Drug Interaction Modelling of a Long Half-Life Substrate and Itraconazole
Clinical Pharmacokinetics, 12/18/09

Acetazolamide and midazolam act synergistically to inhibit neuropathic pain
Pain, 12/16/09

Cyclosporine Versus Tacrolimus in Immunosuppressive Maintenance Regimens in Renal Transplants in Brazil: Survival Analysis from 2000 to 2004
Annals of Pharmacotherapy, 12/16/09

 See all of Drug Interactions